Parasites are engaged in an eternal arms race with their hosts, with both sides continually reacting and adapting to try to either maintain or eliminate infection. One outcome of this coevolutionary struggle can be host species-specificity, where continued cycles of adaptation essentially isolate a parasite within a given host, preventing it from infecting even closely related species.

*Plasmodium* parasites, the causative agents of malaria, are no exception. The most extreme examples are perhaps *Plasmodium falciparum*, which causes most human malaria mortality, and the cluster of ape parasites from which it emerged. Within this subgenus there appears to be remarkably tight host species specificity, with some *Laverania* species infecting chimpanzees and others gorillas, even when the two are sympatric ([@bb0015]). What isolates *Plasmodium* parasites within these closely related primates is not known, although host-parasite protein--protein interactions involved in cellular recognition may provide part of the answer ([@bb0030]). Not all *Plasmodium* parasites are so isolated however. *Plasmodium knowlesi* is perhaps the most widely known example, which primarily infects rhesus macaques but is also the cause of thousands of zoonotic infections in humans ([@bb0020]).

*Plasmodium malariae*, one of the four predominant causes of human malaria, is a case where the species-specificity, or lack thereof, has been frequently disputed. *P. malariae* was almost certainly the first malaria parasite ever observed by Charles Laveran, who won the Nobel Prize for discovering the cause of malaria ([@bb0005]). Found throughout the tropical world from Africa to South America, *P. malariae* remains the most understudied and mysterious human malaria parasite because it causes few complications and is frequently undiagnosed. The question of the origin of *P. malariae* remains disputed, in large part because of the existence of two morphologically very similar, perhaps identical, species --- *Plasmodium rhodaini* in African apes, and *Plasmodium brasilianum* in New World monkeys in South America ([@bb0005]). Cross-species infections shows that both can be forced to cross host barriers experimentally, and *P. brasilianum* is now commonly thought to be an anthroponosis from *P. malariae* parasites first introduced to South America from Africa during European occupation and colonization, although others have argued that transmission originally occurred in the opposite direction ([@bb0005; @bb0025]).

Lalremruata et al. now establish for the first time that cross-species transmission of *P. brasilianum* can happen naturally from monkey to man ([@bb0010]). Surveying remote indigenous communities in the Venezuelan Amazon, they identified human *Plasmodium* infections that were defined as *P. malariae* based on established species-specific diagnostics, but were 100% identical in sequence, at least at the loci investigated, to previously published *P. brasilianum* sequences from South American monkeys. The inference is clear --- individuals in these communities are infected with what would be called *P. brasilianum* if they were isolated from monkeys rather than humans. Phylogenetic analyses incorporating other existing *P. malariae* and *P. brasilianum* sequences identified a single monphyletic clade, with no mutations differentiating them. Lalremruata et al., argue that in South America *P. malariae* and *P. brasilianum* can be considered a single anthropozoonotic species, circulating freely between monkeys and humans ([@bb0010]).

Is it time therefore to retire the name *P. brasilianum* (and perhaps also *P. rhodaini* in Africa), and identify *P. malariae* as the most broadly adapted and successful *Plasmodium* parasite identified to date, capable of infecting a wide range of primate species? Not quite. Lalremruata et al. used a unique sample set from some of the most isolated human communities on the planet, but were limited by the number of loci that they could investigate because so few *P. malariae* and *P. brasilianum* samples have been studied genetically. No reference genome for *P. malariae* currently exists, in large part because of the generally low parasite density found in most *P. malariae* infections, which results in limited DNA yield. While next-generation sequencing technologies have revolutionised the amount of material needed to generate whole genome sequence from many *Plasmodium* species, creating a high quality reference genome from scratch still requires a good quantity of DNA, and preferably requires using multiple sequencing technologies. Once such a reference exists, future studies can amplify and sequence multiple loci from both *P. malariae* and *P. brasilianum*. Even better would be a comprehensive study comparing genomes from both *P. malariae* and *P. brasilianum* from multiple sites across South America, which would finally and definitively establish whether they are the same or distinct species.

Why does all this matter? As the scientific community pushes towards malaria elimination, the question of which *Plasmodium* species have non-human hosts that could serve as a reservoir for continual infections becomes a critical one. For *P. malariae*, the issue of zoonotic infections may be a very difficult problem indeed.
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